Non-Coding RNAs (Ch. 17)

Non-Coding RNAs (ncRNAs) Overview

  • Introduction
      - Some genes do not encode polypeptides but are transcribed into non-coding RNAs (ncRNAs).
      - Estimates of the number of ncRNAs in humans range from several thousand to tens of thousands.
      - In most cell types, ncRNAs are more abundant than messenger RNAs (mRNAs).
      - In a typical human cell:
        - Approximately 20% of transcription involves the production of mRNAs.
        - Approximately 80% of transcription is associated with making ncRNAs.

Overview of Non-Coding RNAs

  • Binding Interactions
      - ncRNAs can bind to different types of molecules.
      - RNA molecules can form stem-loop structures, which may bind to pockets on the surface of proteins.

  • Examples of Abundant ncRNAs
      - The notes do not list specific examples but indicate a focus on those which are abundant in cellular contexts.

Functions of Non-Coding RNAs

  1. Scaffold
       - A ncRNA binds a group of proteins, organizing them into a larger complex.

  2. Guide
       - A ncRNA binds to a protein and directs it to a specific site in the cell.

  3. Alteration of Protein Function or Stability
       - A ncRNA can bind to a protein and alter:
         - The structure of the protein.
         - The ability of the protein to act as a catalyst.
         - The ability of the protein to bind to another molecule.
         - The stability of the protein.

  4. Ribozyme
       - RNA molecules that possess catalytic function.

  5. Blocker
       - An ncRNA physically prevents or blocks a cellular process from occurring.

  6. Decoy
       - An ncRNA recognizes another ncRNA and sequesters it, preventing its action.

Specific Example of ncRNA Functioning

  • MicroRNAs (miRNAs):
       - miRNA binds to mRNA and inhibits translation.
       - miRNA can bind to a decoy ncRNA, allowing translation of the mRNA to occur, demonstrating how decoy ncRNAs can modulate regulatory processes.

Classification of ncRNAs

  • Categories by Length
      - Long non-coding RNAs (lncRNAs):
        - Longer than 200 nucleotides.
      - Small regulatory RNAs (short ncRNAs):
        - Shorter than 200 nucleotides, including microRNAs, typically 20-25 nucleotides long.

RNA World Hypothesis

  • Emergence of Living Cells
      - Living cells may have originated from more primitive structures called protobionts.
      - Protobionts consisted of aggregates of molecules and macromolecules with a boundary (e.g., lipid bilayer).
      - They maintained a distinct internal chemical environment.

  • Characteristics of Protobionts
      - A boundary that separates internal contents from the external environment.
      - Polymers inside capable of information storage and having catalytic functions.
      - Candidates for self-replication.

RNA World

  • Scientists suggest RNA was the first macromolecule in protobionts.

  • The RNA World period featured RNA molecules, but not DNA or proteins.

  • Functions of RNA included:
      1. Information storage via nucleotide base sequences.
      2. Self-replication as a ribozyme, using RNA templates for complementary RNA synthesis.
      3. Catalytic activity, synthesizing polypeptides and other organic molecules.

  • Evolution from RNA to DNA
      - RNA performed information storage and enzymatic functions.
      - DNA allowed RNA to bind cofactors, include modified bases, or bind peptides enhancing catalytic function.
      - DNA is predicted to be a more stable molecule for information storage.
      - Ancestral RNA molecules might have had the ability to synthesize DNA using RNA as a template.

Evolution from RNA to Proteins

  • The emergence of proteins as catalysts conferred significant advantages to early cells.
      - Proteins can perform diverse functions, such as structural roles in cytoskeletal and membrane proteins.

  • Modern RNA's role in protein synthesis includes messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), and even ribozymes, aligning with evolutionary history.

RNA Interference (RNAi)

  • Definition:
      - RNA interference is a regulatory mechanism found in most eukaryotes, mediated by ncRNAs, particularly microRNAs (miRNAs) and small interfering RNAs (siRNAs).

  • MicroRNAs (miRNAs):
       - These are transcribed from endogenous eukaryotic genes and regulate gene expression.
       - A single miRNA can inhibit translation of multiple mRNAs due to partial complementarity.
       - It’s estimated that up to 60% of human genes may be regulated by miRNAs.

  • Small Interfering RNAs (siRNAs):
       - Typically derived from exogenous sources, such as viral infections or experimental treatments.

Mechanism of RNA Interference

  1. Transcription:
       - The synthesis of pri-miRNA, which folds into a hairpin recognized by Drosha and DGCR8.
       - Cleaved to form a pre-miRNA and exported from the nucleus.
       

  2. Processing:
       - The pre-miRNA is cut by dicer into 20 to 25 base pair products, miRNA or siRNA.
       

  3. Formation of RISC (RNA-Induced Silencing Complex):
       - Involves degradation of one strand of the double-stranded RNA.
       - RISC recognizes specific mRNAs through complementary sequences.

  4. Action Mechanism:
       - siRNAs typically lead to complete degradation of their target mRNA, while miRNAs often inhibit translation without degrading mRNA.

Non-Coding RNAs and Genome Defense

  • CRISPR-Cas System:
      - A defensive mechanism found in prokaryotes against bacteriophages, plasmids, and transposons involving ncRNAs.
      - Type II system of CRISPR is discussed.
      - PIWI-interacting RNA (piRNA) interacts with PIWI proteins and inhibits transposable elements' movements.

  • Components of the CRISPR-Cas System:
       - Found in prokaryotic chromosomes (CRISPR locus) first recognized in 1993.
       - Contains repeated sequences and segments derived from bacteriophage DNA.

  • Phases of CRISPR-Cas Defense Mechanism:
      1. Adaptation Phase:
         - Involves acquisition of spacers from previous bacteriophage infections, integrating segments of bacteriophage DNA into CRISPR gene.
      2. Expression Phase:
         - After adaptation, the CRISPR, tracr, and Cas9 genes are expressed, creating pre-crRNA and tracrRNA that interact.
      3. Interference Phase:
         - The specific complementary interactions guide the Cas9 protein to cleave invading DNA, inhibiting phage proliferation.

CRISPR-Cas Technology

  • Growing interest in CRISPR technology for gene editing within living cells.

  • The single guide RNA (sgRNA) links tracrRNA and crRNA, guiding the Cas9 protein to the target gene for editing.

  • Repair options after Cas9 cleavage:
     1. Nonhomologous end joining (NHEJ): Typically results in small indels leading to gene inactivation.
     2. Homologous recombination repair (HRR): Requires the presence of a donor DNA template carrying desired mutations.

  • Applications:
       - CRISPR-Cas technology is utilized across various organisms including mice, human cell lines, and plants, showcasing its versatility and potential in genetic research and modification.